Baldwin Wealth Partners’s Amedisys AMED Stock Holding History

Baldwin Wealth Partners’s Portfolio AMED Stock Details AMED Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q3	–	Sell	-558	Closed	-$28K	–	533
2016 Q2	$28K	Buy	558 +54	+11%	+$2.73K	0.01%	309
2016 Q1	$24K	Buy	+504	New	+$19.4K	﹤0.01%	349
2015 Q4	–	Sell	-25,366	Closed	-$963K	–	237
2015 Q3	$963K	Buy	+25,366	New	+$1.07M	0.16%	125
2015 Q2	–	Sell	-47,521	Closed	-$1.27M	–	250
2015 Q1	$1.27M	Buy	47,521 +12,906	+37%	+$364K	0.19%	110
2014 Q4	$1.02M	Buy	+34,615	New	+$855K	0.15%	133

Other funds holding AMED

KKRC

Kohlberg Kravis Roberts & Co New York $5.35B AUM 63.01% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

BlackRock Advisors Wilmington, Delaware $98.8B AUM 15.8% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

GGHC

Gilder Gagnon Howe & Co New York $8.34B AUM 46.58% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

Baldwin Wealth Partners's AMED Position: Q3 2016 in Review

Baldwin Wealth Partners sold out of Amedisys (AMED) in Q3 2016, closing a stake of 558 shares — an estimated $28K sold.

Baldwin Wealth Partners first reported a position in AMED in Q4 2014 and held it in 5 quarters. The position peaked at $1.27M in Q1 2015. 153 funds tracked by Wall St. Rank hold AMED as of Q3 2016.

Baldwin Wealth Partners reported no remaining Amedisys position as of Q3 2016 after selling out during the quarter.
Baldwin Wealth Partners sold 558 Amedisys shares in Q3 2016, an estimated $28K.
Baldwin Wealth Partners first reported a position in Amedisys in Q4 2014 and held it in 5 quarters.
Baldwin Wealth Partners's Amedisys position peaked at $1.27M in Q1 2015.
153 funds tracked by Wall St. Rank held Amedisys as of Q3 2016.

Based on Baldwin Wealth Partners's 13F filing for Q3 2016, filed 8 Nov 2016.